Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/
You can print this page and show it to your doctor.

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

ProPublica's Dollars for Docs database lets you search for payments to U.S.-based doctors made by pharmaceutical and medical device companies between August 2013 and December 2018. The disclosure of these payments is required under the Physician Payments Sunshine Act, a provision of the 2010 Affordable Care Act.

About This Information

  • The information that appears here comes directly from the federal government. Companies must attest to its accuracy, and doctors have the ability to contest information they believe is in error.
  • This site includes payments for such activities as speaking, consulting, meals, travel and royalties. It does not include payments for clinical research.
  • It is legal for companies to make payments to doctors as long as the payments are not a kickback or inducement to use their products.
  • Some doctors say collaborative relationships, particularly those involving research, are necessary to develop new treatments and cures. But many ethicists have raised questions about the payments, and studies show that they may influence doctors' prescribing decisions.
  • Only you can decide if this matters to you and if so, whether you want to talk with your doctor about it. If you plan to talk with your doctor (or if you already have), please help us by filling out this short survey: propub.li/participate-d4d

Preparing for Your Conversation

If you decide you'd like to talk to your doctor about this, please keep in mind:

  • Many health care professionals in our database have similar names, so you should start by asking your doctor if the person mentioned in this payment record is really him/her.
  • Your doctor may not know he or she is listed as receiving payments, especially if the payments are small. You can direct your doctor to this site (the URL will be printed at the top of the payment record) or directly to the government's site here: https://openpaymentsdata.cms.gov/physician/111056
  • Some doctors are happy to discuss this information with you. Others might not be. The best approach is to ask questions and to not be accusatory.

Questions You Might Want to Ask

  • Is this you?
  • What type of work do you do with these companies?
  • Have you prescribed me any drugs that are manufactured by companies you've taken payments from?
  • Are there non-drug alternatives that I may want to consider first?
  • Are there less expensive generic alternatives to the drugs you have prescribed?
  • What devices have you used in my care that are manufactured by companies you've taken payments from?

Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/doctors/pid/111056
If you spot an error, please let us know at [email protected].

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

CHARLES RUDIN

Listed Specialty: Hematology & Oncology
1275 YORK AVE, NEW YORK, NY, 10065-6007

2018 Payments: At a Glance

32

payments

$27,327

payment total

8

companies paid this doctor

Types of Payments

Category Payments Payment Value
Consulting
 13 $24,706
Travel and Lodging
 9 $1,997
Food and Beverage
 9 $622
Education
 1 $2

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments†
ALECENSA

drug

 $7,726
TECENTRIQ

drug

 $7,726
Payments with no listed product

N/A

 $6,398
CC-90011

drug

 $4,844
OPDIVO

drug

 $4,534
NON-COVERED PRODUCT

drug

 $2,922
IMFINZI

drug

 $1,611
SOMATULINE

drug

 $1,389
NPLATE

drug

 $825
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

Payment Details

When How Much Related To What For From Third Party Payee
Jun 1, 2018 $4,200 CC-90011 Consulting CELGENE CORPORATION
Feb 20, 2018 $4,000 ALECENSA TECENTRIQ Consulting GENENTECH USA, INC.
Oct 12, 2018 $3,850 No Listed Product Consulting AMGEN INC.
Sep 26, 2018 $2,660 ALECENSA TECENTRIQ NON-COVERED PRODUCT Consulting F. HOFFMANN-LA ROCHE AG
Aug 1, 2018 $2,250 No Listed Product Consulting ABBVIE, INC.
Jan 22, 2018 $1,980 OPDIVO Consulting E.R. SQUIBB & SONS, L.L.C.
Jul 19, 2018 $1,485 OPDIVO Consulting E.R. SQUIBB & SONS, L.L.C.
Nov 19, 2018 $1,350 SOMATULINE Consulting IPSEN INNOVATION
Aug 10, 2018 $825 NPLATE Consulting AMGEN INC.
Mar 28, 2018 $537 IMFINZI Consulting ASTRAZENECA PHARMACEUTICALS LP
Apr 3, 2018 $537 IMFINZI Consulting ASTRAZENECA PHARMACEUTICALS LP
Aug 13, 2018 $537 IMFINZI Consulting ASTRAZENECA PHARMACEUTICALS LP
Aug 7, 2018 $495 OPDIVO Consulting E.R. SQUIBB & SONS, L.L.C.
Feb 20, 2018 $448 ALECENSA TECENTRIQ Travel and Lodging GENENTECH USA, INC.
Jun 1, 2018 $447 CC-90011 Travel and Lodging CELGENE CORPORATION
Jul 19, 2018 $447 OPDIVO Travel and Lodging E.R. SQUIBB & SONS, L.L.C.
Feb 20, 2018 $256 ALECENSA TECENTRIQ Travel and Lodging GENENTECH USA, INC.
Sep 26, 2018 $200 ALECENSA TECENTRIQ NON-COVERED PRODUCT Travel and Lodging F. HOFFMANN-LA ROCHE AG
Jun 1, 2018 $124 CC-90011 Food and Beverage CELGENE CORPORATION
Feb 21, 2018 $100 ALECENSA TECENTRIQ Food and Beverage GENENTECH USA, INC.

For ease of printing, 20 payments are displayed, the largest appearing on top. For a full list of payments, please visit: https://projects.propublica.org/docdollars/doctors/pid/111056

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.